drugset / Trial / NCT00723502
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to compare the H. pylori eradication rates with Finafloxacin in combination with Amoxicillin or Esomeprazole. The secondary objective is to evaluate and compare the safety and tolerability of multiple oral doses of Finafloxacin plus Amoxicillin versus Finafloxacin plus Esomeprazole.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Finafloxacin | Small molecule | 400 mg | Oral |